Humoral response to cancer as a tool for biomarker discovery.
about
Novel technologies and emerging biomarkers for personalized cancer immunotherapyA high-throughput O-glycopeptide discovery platform for seromic profiling.Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis.Differential influence of anticancer treatments and angiogenesis on the seric titer of autoantibody used as tumor and metastasis biomarker.Preliminary study of thyroid and colon cancers-associated antigens and their cognate autoantibodies as potential cancer biomarkers.Autoantibody against WD repeat domain 1 is a novel serological biomarker for screening of thyroid neoplasia.Combined measurement of CA 15-3 with novel autoantibodies improves diagnostic accuracy for breast cancerHypoxia integration in the serological proteome analysis unmasks tumor antigens and fosters the identification of anti-phospho-eEF2 antibodies as potential cancer biomarkers.Serological immune response against ADAM10 pro-domain is associated with favourable prognosis in stage III colorectal cancer patientsSerum anti-AEG-1 auto-antibody is a potential novel biomarker for malignant tumorsDendritic cell-based vaccination in metastatic melanoma patients: phase II clinical trial.Systematic evaluation of immune regulation and modulationA new type of protein chip to detect hepatocellular carcinoma-related autoimmune antibodies in the sera of hepatitis C virus-positive patientsThe Immune Regulator VTCN1 Gene Polymorphisms and Its Impact on Susceptibility to Breast Cancer.Serological antibodies against LY6K as a diagnostic biomarker in esophageal squamous cell carcinoma.[Autoantibodies as the early diagnostic biomarkers for lung cancer].Immunoglobulin g from breast cancer patients regulates MCF-7 cells migration and MMP-9 activity by stimulating muscarinic acetylcholine receptors
P2860
Q26770780-38BC95CD-A391-4817-B4C9-87FBFE0D384FQ33667213-C6DA2357-6E90-4764-ADA3-331ADA6ACEA5Q33895872-012E0D6C-EA6B-406D-8317-35F6CDC79FC1Q34009845-2A4D9F6A-4C46-4DC0-BE4A-62E9C73FB468Q34276070-7DE13633-731D-448C-BEC2-9BE73B5EC979Q34502078-DE9DC57D-DBAA-4DEB-97CC-651F5C213A54Q34660278-0281F99D-1EED-4E8D-8792-43997F39734DQ35018525-9C123D07-406E-4D89-BAB1-CB281D032D37Q36102628-ED65F3D0-38F0-4D20-A9F3-D52FA1A3F07DQ36110472-51F60A6D-BCF8-4923-A26D-CD239C69926BQ36642308-8F2C387E-051A-467B-8570-E2C3D73EB39CQ37713498-59001A94-3E3A-4E10-A478-67449015C125Q41882623-ECC509B8-D783-4B7C-B9E2-FB74736452F6Q48177973-FB187F59-8D4B-4D9B-843D-160783A131F9Q54314047-F68F3454-57C7-409A-8173-920F63115C8BQ55436520-92DDD146-0BB7-43B4-92B9-EBACF4A6AE15Q56773128-806672A1-C0FE-4539-8749-2EA3506A4355
P2860
Humoral response to cancer as a tool for biomarker discovery.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Humoral response to cancer as a tool for biomarker discovery.
@ast
Humoral response to cancer as a tool for biomarker discovery.
@en
type
label
Humoral response to cancer as a tool for biomarker discovery.
@ast
Humoral response to cancer as a tool for biomarker discovery.
@en
prefLabel
Humoral response to cancer as a tool for biomarker discovery.
@ast
Humoral response to cancer as a tool for biomarker discovery.
@en
P2093
P1476
Humoral response to cancer as a tool for biomarker discovery.
@en
P2093
P304
P356
10.1016/J.JPROT.2009.06.004
P577
2009-06-16T00:00:00Z